117 related articles for article (PubMed ID: 29568966)
1. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y
Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional analysis of variant haplotypes in the 5'-flanking region of protein phosphatase 2A-Bδ gene.
Chen HF; Lin LN; Chen YX; Wan JX; Luo J; Zhang CZ; Li XJ; Hu YM; Mai JR; Chen W; Lin ZN; Lin YC
PLoS One; 2012; 7(4):e35524. PubMed ID: 22539979
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.
Joseph BK; Liu HY; Francisco J; Pandya D; Donigan M; Gallo-Ebert C; Giordano C; Bata A; Nickels JT
J Biol Chem; 2015 Apr; 290(17):10588-98. PubMed ID: 25694423
[TBL] [Abstract][Full Text] [Related]
5. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
[TBL] [Abstract][Full Text] [Related]
6. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
7. LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.
Qiu YS; Jiang NN; Zhou Y; Yu KY; Gong HY; Liao GJ
Int J Mol Med; 2018 May; 41(5):2755-2763. PubMed ID: 29436606
[TBL] [Abstract][Full Text] [Related]
8. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
10. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer.
Zhang Y; Li CF; Ma LJ; Ding M; Zhang B
Int J Oncol; 2016 Sep; 49(3):1068-80. PubMed ID: 27315344
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
Yuan X; Zhang T; Zheng X; Zhang Y; Feng T; Liu P; Sun Z; Qin S; Liu X; Zhang L; Song J; Liu Y
Oncol Rep; 2017 Sep; 38(3):1733-1741. PubMed ID: 28677734
[TBL] [Abstract][Full Text] [Related]
13. GNA13 as a prognostic factor and mediator of gastric cancer progression.
Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.
Geng Q; Liu J; Gong Z; Chen S; Chen S; Li X; Lu Y; Zhu X; Lin HK; Xu D
Mol Cancer; 2017 Apr; 16(1):83. PubMed ID: 28446188
[TBL] [Abstract][Full Text] [Related]
15. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
16. Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling.
Dou N; Yu S; Ye X; Yang D; Li Y; Gao Y
Oncotarget; 2016 Dec; 7(52):86161-86173. PubMed ID: 27863387
[TBL] [Abstract][Full Text] [Related]
17. Expression of transmembrane protein 41A is associated with metastasis via the modulation of E‑cadherin in radically resected gastric cancer.
Lin B; Xue Y; Qi C; Chen X; Mao W
Mol Med Rep; 2018 Sep; 18(3):2963-2972. PubMed ID: 30015937
[TBL] [Abstract][Full Text] [Related]
18. PPP2R2D suppresses IL-2 production and Treg function.
Pan W; Sharabi A; Ferretti A; Zhang Y; Burbano C; Yoshida N; Tsokos MG; Tsokos GC
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897879
[TBL] [Abstract][Full Text] [Related]
19. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
